MARKET

BBP

BBP

Virtus LifeSci Biotech Products ETF
NYSEARCA

Real-time Quotes | Provided by Morningstar

55.52
+0.63
+1.15%
Closed 16:00 03/01 EST
OPEN
55.40
PREV CLOSE
54.89
HIGH
55.68
LOW
55.40
VOLUME
826
TURNOVER
--
52 WEEK HIGH
61.39
52 WEEK LOW
30.83
TOTAL ASSET
30.14M
YTD YIELD
3.89%
1D
5D
1M
3M
1Y
5Y
News
Performance
Mystery Surrounds $7 Billion Outflow From Vanguard S&P 500 Fund
Bloomberg · 12/04/2020 14:01
Biotech Investing In A Time Of The Coronavirus
A broad and diverse effort is underway by biotech companies to solve the terrible riddle of the Coronavirus.Firms are forging ahead with testing, treatment and vaccine research and product development.Results of even the most promising treatments, however, are not yet clear cut. Even those that may be are not proof a bullish thesis for those companies that have developed them.Biotech investing is risky. The temptations of building a large position in a COVID 19-engaged public company are obvious.A wise investor would be well-served by opening or adding to such positions with a measure of caution.
Seekingalpha · 10/09/2020 16:49
Biotechnology Innovation During COVID-19
Seeking Alpha - Article · 06/11/2020 07:47
ACADIA Pharmaceuticals: The Worst-Case Scenario For Investors
Seeking Alpha - Article · 06/08/2020 00:01
ACADIA: The Company's Perspectives In Numbers.
Seeking Alpha - Article · 05/15/2020 15:18
Will These Tech Stock Valuations Last?
Seeking Alpha - Article · 02/13/2020 13:06
Should Investors Avoid U.S. Healthcare Stocks In An Election Year?
Seeking Alpha - Article · 02/10/2020 14:35
Brookfield Asset Management: Strong And Getting Stronger
Seeking Alpha - Article · 10/06/2019 13:28
More
No Data
Learn about the latest financial forecast of BBP. Analyze the recent business situations of Virtus LifeSci Biotech Products ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
Ratings
Date
Period
Agency
Ratings
08/31/2020
3 Year
Morningstar
08/31/2020
5 Year
Morningstar
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Day
-2.8076%
--
1-Week
2.4552%
--
1-Month
-2.4491%
--
3-Month
-1.9357%
--
6-Month
6.0962%
--
YTD
3.8897%
--
1-Year
24.2059%
--
5-Year
7.5540%
--
Since Inception
11.2432%
--
No Data
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
No Data
Profile
Fund Name
Virtus LifeSci Biotech Products ETF
Risk
Low risk
Inception Date
2014-12-16
Benchmark
Dow Jones US Healthcare TR
Advisor Company
Virtus
Custodian
The Bank of New York Mellon
Manager
Brown/Kadushin